AZN vs UVSP · P/E 28, $288.38B cap vs P/E 12, rev $171.8M
AstraZeneca PLC (AZN) versus Univest Corporation Pennsylvania (UVSP) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Univest Corporation Pennsylvania (UVSP) is a banks - regional company listed on NASDAQ.
AZN does not have a complete income-statement cache yet.
Latest reported UVSP revenue for 2026-06-30 was $171.8M. Net income was $50.0M. Revenue was up 96.5% from 2026-03-31 to 2026-06-30. UVSP currently screens at market cap $1.15B and trailing P/E 12.5.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. UVSP currently screens at market cap $1.15B and trailing P/E 12.5.
Not investment advice. Open the AZN and UVSP stock pages for the full models.
Not investment advice.